Codexis Inc (CDXS) - Total Liabilities
Based on the latest financial reports, Codexis Inc (CDXS) has total liabilities worth $85.42 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Codexis Inc cash conversion from operations to assess how effectively this company generates cash.
Codexis Inc - Total Liabilities Trend (2006–2024)
This chart illustrates how Codexis Inc's total liabilities have evolved over time, based on quarterly financial data. Check CDXS asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Codexis Inc Competitors by Total Liabilities
The table below lists competitors of Codexis Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Deoleo S.A
MC:OLE
|
Spain | €380.80 Million |
|
Cognition Therapeutics Inc
NASDAQ:CGTX
|
USA | $6.87 Million |
|
Klil Industries Ltd
TA:KLIL
|
Israel | ILA113.55 Million |
|
Fossil Group Inc
NASDAQ:FOSL
|
USA | $604.95 Million |
|
Oriental Aromatics Limited
NSE:OAL
|
India | Rs5.31 Billion |
|
Masisa
SN:MASISA
|
Chile | CL$195.61 Million |
|
GAMCO Natural Resources Gold and Income Closed Fund
NYSE:GNT
|
USA | $36.31 Million |
Liability Composition Analysis (2006–2024)
This chart breaks down Codexis Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Codexis Inc market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.12 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.22 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.69 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Codexis Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Codexis Inc (2006–2024)
The table below shows the annual total liabilities of Codexis Inc from 2006 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $82.08 Million | +64.35% |
| 2023-12-31 | $49.95 Million | -52.70% |
| 2022-12-31 | $105.60 Million | +28.79% |
| 2021-12-31 | $81.99 Million | +59.07% |
| 2020-12-31 | $51.54 Million | +18.34% |
| 2019-12-31 | $43.56 Million | +98.19% |
| 2018-12-31 | $21.98 Million | -24.42% |
| 2017-12-31 | $29.08 Million | +75.71% |
| 2016-12-31 | $16.55 Million | -23.98% |
| 2015-12-31 | $21.77 Million | -0.20% |
| 2014-12-31 | $21.81 Million | +25.66% |
| 2013-12-31 | $17.36 Million | -19.36% |
| 2012-12-31 | $21.52 Million | -35.23% |
| 2011-12-31 | $33.23 Million | -2.08% |
| 2010-12-31 | $33.94 Million | -45.44% |
| 2009-12-31 | $62.20 Million | -68.90% |
| 2008-12-31 | $200.01 Million | -0.50% |
| 2007-12-31 | $201.01 Million | +102.17% |
| 2006-12-31 | $99.42 Million | -- |
About Codexis Inc
Codexis, Inc. provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the … Read more